ALLENDALE, N.J.--(BUSINESS WIRE)--Stryker’s Spine division today announced the launch of its LITe BIO Delivery System, a hand-held device used to facilitate delivery of bone graft material to spinal surgery sites, which simplifies graft delivery, accommodates a surgeon’s preferred graft materials,1 and allows for direct visualization of graft placement.
The unique design of the LITe BIO Delivery System provides surgeons with a single-handed method to deliver any type of autograft, allograft, or synthetic bone graft material without obstructing visibility. The innovative delivery tool provides tactile, visual, and audible confirmation of bone graft delivery, and the mallet-free system eliminates the impaction of bone graft.
According to Bradley Paddock, President of Stryker’s Spine division, the new LITe BIO Delivery System offers significant benefits. Although conventional bone graft delivery methods can accommodate any type of graft material, they can be cumbersome to use. Pre-filled delivery devices are more streamlined but can only be used with specific graft materials.
“Our new LITe BIO Delivery System is innovative in the marketplace, simplifying graft delivery for spine surgeons,” Paddock said. “Its sleek, versatile design can accommodate any bone graft material and provides surgeons with direct visualization to aid in the precise placement of the graft, which is important for optimal fusion. No other system combines all of these key features—the LITe BIO Delivery System truly is advanced delivery, simplified.”
The LITe BIO Delivery System is the latest addition to Stryker’s comprehensive spine portfolio, which includes products and instruments designed for access, interbody, fixation, and fusion. The patented system can be used for any type of spine fusion surgery, including minimally invasive procedures. The low-profile design allows visibility through a decompression tube without obstructing view. A radiolucent strip facilitates visualization under fluoroscopy, and the disposable cannula allows for delivery of up to 5cc of bone graft at one time.
Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at www.stryker.com.
1. FDA Cleared Indications for Use: The LITe BIO Delivery System is intended to deliver autograft, allograft or synthetic bone graft materials to all orthopaedic surgical sites.
Content ID BILIT-PR-1_11158